ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Washington Intensive Supervision Program

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01343472
Recruitment Status : Completed
First Posted : April 28, 2011
Last Update Posted : April 10, 2018
Sponsor:
Information provided by (Responsible Party):
Brett T. Leach, Pepperdine University

Brief Summary:
This study entails an evaluation of the Washington Intensive Supervision Program (WISP). The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU).

Condition or disease Intervention/treatment Phase
Behavior Drug Users Behavioral: WISP supervision Behavioral: Parole-as-usual Not Applicable

Detailed Description:
This study entails an evaluation of the Washington Intensive Supervision Program (WISP). WISP is a program targeting high-risk parolees in Seattle, and is modeled after the HOPE program in Hawaii. The purpose of the evaluation is to test whether subjects assigned to WISP perform better than those assigned to parole-as-usual (PAU) on a number of outcomes, including drug use, missed appointments, recidivism, prison and jail stays, and parole revocations. WISP uses regular random drug testing and close community supervision, paired with swift and certain, but modest sanctions for every detected violation.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 70 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: Evaluation of the Washington Intensive Supervision Program
Study Start Date : January 2011
Actual Primary Completion Date : January 2012
Actual Study Completion Date : June 2012

Arm Intervention/treatment
Experimental: WISP supervision
Parolee supervised under WISP parole model.
Behavioral: WISP supervision
WISP entails a warning session (Orientation Hearing) where the rules of parole are laid out and parolees are told that any violation of stated parole conditions will be sanctioned with a brief jail term (typically a few days in jail). WISP includes regular random drug testing.
Other Name: HOPE supervision
Active Comparator: Parole-as-usual
Parolees supervised under Washington State's parole-as-usual
Behavioral: Parole-as-usual
Parolees are supervised under standard parole supervision practice in Washington State.
Other Name: PAU



Primary Outcome Measures :
  1. Revocation rate [ Time Frame: 12 months ]
    Percentage of subjects in each condition who are revoked from parole and returned to prison


Secondary Outcome Measures :
  1. % positive drug tests [ Time Frame: 12 months ]
    Percentage of random and scheduled drug tests that test positive for illicit drugs

  2. Days incarcerated [ Time Frame: 12 months ]
    Total number of days incarcerated in jail or prison

  3. % Missed appointments [ Time Frame: 12 months ]
    Percentage of parole appointments that are missed.

  4. New arrests [ Time Frame: 12 months ]
    Number of new arrests.

  5. Assessed risk [ Time Frame: 12 months ]
    Parolee risk assessment (high, medium, low)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inmates released by DOC to community corrections supervision
  • Supervised out of the Seattle CJC (Community Justice Center) to include field offices and offenders from the downtown "Metro" unit, Southeast Seattle unit, Northgate (north Seattle) and West Seattle.
  • Have a parole supervision discharge date at least one year from the date of release from entry into WISP

Exclusion Criteria:

  • Level III Sex Offenders
  • Existing assignment to supervision that precludes WISP. These include: Drug Offender Sentencing Alternative (DOSA)and Special Sex Offender Sentencing Alternative (SSOSA).
  • Dangerously Mentally Ill (DMIO)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01343472


Locations
United States, Washington
Seattle Community Justice Center
Seattle, Washington, United States
Sponsors and Collaborators
Pepperdine University
Investigators
Principal Investigator: Angela Hawken, PHD Pepperdine University

Responsible Party: Brett T. Leach, Regulatory Affairs Specialist, Pepperdine University
ClinicalTrials.gov Identifier: NCT01343472     History of Changes
Other Study ID Numbers: SPP0311F08
First Posted: April 28, 2011    Key Record Dates
Last Update Posted: April 10, 2018
Last Verified: April 2018

Keywords provided by Brett T. Leach, Pepperdine University:
Behavior
Drug users